| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/03/2004 | EP1392842A2 Recombinant vaccinia viral vectors |
| 03/03/2004 | EP1392838A1 Pseudotyping vih-1 vectors with the aid of rhabdovirus envelopes |
| 03/03/2004 | EP1392833A2 Site-targeted transformation using amplification vectors |
| 03/03/2004 | EP1392734A1 Hevein-binding monoclonal antibodies |
| 03/03/2004 | EP1023467B1 Method for measuring viral infectivity |
| 03/03/2004 | EP0871459B1 Vector and method of use for nucleic acid delivery to non-dividing cells |
| 03/03/2004 | EP0733103B1 Generation of high titers of recombinant aav vectors |
| 03/03/2004 | CN1140628C Humaninterleukin-12 recombinant insect virus strain and its prepn. method |
| 03/03/2004 | CN1140627C Recombinant virus of human vascular endothelial growth inhibitor |
| 03/03/2004 | CN1140626C Recombination I-type herpes simplex virus and its application |
| 03/02/2004 | US6700038 Insect viral vectors useful in the transfer of genes to plants, insects and other hosts |
| 03/02/2004 | US6699701 Method and device for sanitation using bacteriophages |
| 03/02/2004 | US6699690 Linked and controlling the expression of a heterologous enzyme, for example varicella zoster virus thymidine kinase or non-mammaliam cytosine deaminase |
| 03/02/2004 | US6699663 Molecular sequence of swine retrovirus |
| 03/02/2004 | US6699657 In vitro system for replication of RNA-dependent RNA polymerase (RDRP) viruses |
| 03/02/2004 | US6699480 Vaccine compositions |
| 03/02/2004 | US6699479 Recombinant newcastle disease virus as an embryo vaccine |
| 03/02/2004 | US6699478 Does not induce enhanced disease (e.g., atypical pulmonary inflammation) |
| 03/02/2004 | US6699476 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
| 03/02/2004 | CA2229405C Methods for enhancing the production of interferon in cell culture |
| 02/26/2004 | WO2004016794A1 Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines |
| 02/26/2004 | WO2004016732A2 Astrocyte modulated genes and uses thereof |
| 02/26/2004 | WO2004016222A2 Hepatitis c viral-like particle purification |
| 02/26/2004 | WO2004016151A2 Pthrp-derived modulators of smooth muscle proliferation |
| 02/26/2004 | WO2003098991A3 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 02/26/2004 | WO2003054210B1 Regulated nucleic acid expression system |
| 02/26/2004 | WO2003029412A3 Restricted expression lentivial vectors |
| 02/26/2004 | US20040039187 Chimeric GB virus B (GBV-B) |
| 02/26/2004 | US20040038924 Adenovirus serotype 30 (Ad30) |
| 02/26/2004 | US20040038410 Composition for the preservation of viruses |
| 02/26/2004 | US20040038405 Vectors and viral vectors, and packaging cell lines for propagating same |
| 02/26/2004 | US20040038403 Replication-defective; does not rely on use of tumor specific promoters |
| 02/26/2004 | US20040038402 Gene therapy; for production of transgenic animal models |
| 02/26/2004 | US20040038356 Method and kit for discontinuous density gradient centrifugation to separate a minimum of two substances in a sample; method and kit use is made of colloidal density media and low-density solutions |
| 02/26/2004 | US20040038333 Methods for protein refolding |
| 02/26/2004 | US20040038280 Large circular sense molecule array |
| 02/26/2004 | US20040038205 Modified adenoviral fiber and uses |
| 02/26/2004 | US20040038203 Comprises nucleotide sequences coding yaba monkey tumor viral protein for treatment and prevention of autoimmune diseases |
| 02/26/2004 | US20040038199 Phenotyping assay and reagents therefor |
| 02/26/2004 | US20040038198 Comprises nucleotide sequences coding bovine viral diarrhea virus (BVDV) particles for use in vaccine development; veterinary medicine |
| 02/26/2004 | US20040037850 Incapable of expressing a functional g-protein due to a mutation in the gene encoding it |
| 02/26/2004 | US20040037847 Assays for compounds that modulate rhadino virus lana action in trans on a unit of rhadino virus dna to mediate efficient episome persistence |
| 02/26/2004 | DE10237639A1 Preparing virus-like particles, useful as gene therapy vectors, comprises assembling capsomers, optionally with active molecules attached, in presence of nonionic stabilizers |
| 02/26/2004 | CA2535748A1 Pthrp-derived modulators of smooth muscle proliferation |
| 02/26/2004 | CA2495680A1 Hepatitis c viral-like particle purification |
| 02/25/2004 | EP1390517A2 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins |
| 02/25/2004 | EP1390476A1 Mosaic adenoviral vectors |
| 02/25/2004 | EP1390398A2 Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization |
| 02/25/2004 | EP1390046A2 Treatment of neoplasms with viruses |
| 02/25/2004 | EP0948351B1 Synthetic hpv16 virus-like particles |
| 02/25/2004 | CN1478147A Composition of carrier granules capable of producing RNA virus and based on RNA virus and its method |
| 02/25/2004 | CN1478143A Tumor cell internal specific proliferated virus capable of high-effectively expressing tumor angiogenesis inhibiting factor and its application |
| 02/25/2004 | CN1477973A Split enveloped virus preparation |
| 02/25/2004 | CN1477964A Treatment of neoplasms with viruses |
| 02/25/2004 | CN1477192A Recombinant pseudo-rabies virus expressing swine parvovirus VP2 gene and vacine and its preparation method |
| 02/25/2004 | CN1139656C Quick high-effective separation and purification method of virus related to recombinant adenovirus and its application |
| 02/24/2004 | US6696562 Avian astrovirus |
| 02/24/2004 | US6696295 Transducing phages |
| 02/24/2004 | US6696281 Chimeric flavivirus vaccines |
| 02/24/2004 | US6696278 Method for transfer of DNA segments |
| 02/24/2004 | US6696273 FEBP1 Protein: vector, host cells and method for making FEBP1 protein |
| 02/24/2004 | US6696242 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 02/24/2004 | US6696019 High and low pressure cycles |
| 02/24/2004 | CA2102036C Vaccines raising an immunological response against the disease caused by the iowa strain of porcine reproductive and respiratory syndrome virus |
| 02/19/2004 | WO2004015142A1 Uncoupling of dna propagation and expression of protein for phage display |
| 02/19/2004 | WO2004015118A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/19/2004 | WO2004014314A2 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | WO2003097797A3 Methods of adenovirus purification |
| 02/19/2004 | WO2003088994A3 Modified vaccinia virus ankara for the vaccination of neonates |
| 02/19/2004 | WO2003052051A3 Adeno-associated virus (aav) serotype 8 sequences |
| 02/19/2004 | WO2003050275A3 Method of isolation and purification of trypsin from pronase and use thereof |
| 02/19/2004 | WO2002097072A8 Influenza vaccine composition |
| 02/19/2004 | WO2002086101A3 Core-glycosylated hcv envelope proteins |
| 02/19/2004 | WO2002086100A3 Expression of core-glycosylated hcv envelope proteins in yeast |
| 02/19/2004 | WO2002077206A9 Compositiona and methods useful for hcv infection |
| 02/19/2004 | WO2002046477A3 Endogenous retroviruses up-regulated in prostate cancer |
| 02/19/2004 | US20040033595 Conditionally replicating vectors for inhibiting viral infections |
| 02/19/2004 | US20040033594 Comprises RNA viral sequences for use in development of diagnostics and genetic vaccines against viral infection |
| 02/19/2004 | US20040033585 Preparing tobbaco mosaic viral particles comprising therapeutic polypeptides for treatment of infectious diseases and tumors; immunotherapy; genetic vaccines |
| 02/19/2004 | US20040033584 Using immunoglobulins to diagnose and treat viral, fungal, bacterial and parasitic infections of the reticuloendothelial system; vetrinary medicine; immunotherapy |
| 02/19/2004 | US20040033527 Methods of using a three-dimensional model of a Fc epsilon receptor alpha chain |
| 02/19/2004 | US20040033487 Comprises nucleotide sequences coding associated with glycosylation of viral structural polypeptides; prototype immunogens for treatment and prevention of viral disease; genetic vaccines |
| 02/19/2004 | US20040033211 Antigen arrays for treatment of bone disease |
| 02/19/2004 | CA2818693A1 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | CA2494844A1 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | CA2493716A1 Uncoupling of dna propagation and expression of protein for phage display |
| 02/19/2004 | CA2489301A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/18/2004 | EP0817851B1 Dna encoding human papilloma virus type 18 |
| 02/18/2004 | EP0731838B1 Binding structures directed against the ca55.1 antigen |
| 02/18/2004 | CN1476483A Modified vaccinia ankara virus variant |
| 02/18/2004 | CN1138564C Influenza vaccine |
| 02/17/2004 | US6692956 Recombinant adenoviral vectors |
| 02/17/2004 | US6692750 Introducing into cells recombinant alphavirus rna genome and helper rna encoding alphavirus structural proteins, including coding sequences for proteins and cis acting replication signals; incubating to produce infectious virus particles |
| 02/12/2004 | WO2004013318A1 Method for inducing complete hepatitis c virus (hcv) replication in vitro |
| 02/12/2004 | WO2004013317A1 A method of obtaining a bacteriophage strain of increased affinity to eukaryotic cells, preparations containing it, and applications of bacteriophages |
| 02/12/2004 | WO2004013277A2 Large circular sense molecule array |
| 02/12/2004 | WO2003076583A3 Genetically engineered phage and the use of genetically engineered phage to deliver nucleic acid to bacteria |
| 02/12/2004 | WO2003068923A9 Signal for packaging of influenza virus vectors |
| 02/12/2004 | WO2003035012A3 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 02/12/2004 | WO2003029416A3 Recombinant respiratory syncytial viruses with deleted surface glycoprotein genes and uses thereof |